In the SELECT trial (among others), it showed lower rates of major adverse cardiovascular events (such as heart attacks and strokes) compared to placebo, especially in overweight or obese patients
It emphasizes that such a lapse in coverage, if it's not at least as good as Medicare's prescription drug coverage, can have significant consequences
Topiramate may also cause birth defects (particularly there is a risk of cleft lip and/or palate and low birth weight)
References Veech, R
Tirzepatide is a GLP-1 + GIP receptor agonist engineered for individuals seeking effective weight management, appetite control, and metabolic optimization in a once-daily, mint-flavored sublingual (under the tongue) tablet
Compounded GLP-1 Costs Brand-name Ozempic typically costs $900$1,500 monthly without insurance, while GLP-1 competitor Wegovy ranges from $1,100$1,400 per injection pen